|
SNX5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30570000003816E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10029999994743E-06 |
| Normal-vs-Stage2 |
3.770800E-04 |
| Normal-vs-Stage3 |
7.918200E-03 |
| Normal-vs-Stage4 |
1.844740E-03 |
| Stage1-vs-Stage2 |
6.639000E-01 |
| Stage1-vs-Stage3 |
1.738550E-01 |
| Stage1-vs-Stage4 |
7.737000E-01 |
| Stage2-vs-Stage3 |
4.802400E-01 |
| Stage2-vs-Stage4 |
5.564800E-01 |
| Stage3-vs-Stage4 |
3.054800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.60319999999281E-05 |
| Normal-vs-AfricanAmerican |
7.23059999652165E-08 |
| Normal-vs-Asian |
7.431700E-02 |
| Caucasian-vs-AfricanAmerican |
1.208410E-01 |
| Caucasian-vs-Asian |
8.370800E-01 |
| AfricanAmerican-vs-Asian |
4.342800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.23819999989728E-07 |
| Normal-vs-Female |
1.219970E-04 |
| Male-vs-Female |
3.406800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.84270000000475E-05 |
| Normal-vs-Extreme_Weight |
1.34410000018903E-07 |
| Normal-vs-Obese |
1.543470E-03 |
| Normal-vs-Extreme_Obese |
1.040670E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.266000E-01 |
| Normal_Weight-vs-Obese |
2.139200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.513000E-01 |
| Extreme_Weight-vs-Obese |
5.888000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.880000E-01 |
| Obese-vs-Extreme_Obese |
1.520250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.277140E-03 |
| Normal-vs-Age(41-60Yrs) |
4.754000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.67219999963808E-07 |
| Normal-vs-Age(81-100Yrs) |
5.241800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.712800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.481800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.732800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.663900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.081600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.65220000195532E-08 |
| Normal-VS-Type2 PRCC |
1.095020E-03 |
| Normal-VS-KIRP CIMP |
3.11149999998594E-06 |
| Normal-VS-Unclassified PRCC |
2.165700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.535500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.652100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.882400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.462600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.289600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.039800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83449999999752E-05 |
| Normal-vs-N1 |
5.781500E-03 |
| Normal-vs-N2 |
5.403100E-03 |
| N0-vs-N1 |
3.726200E-01 |
| N0-vs-N2 |
5.314200E-01 |
| N1-vs-N2 |
3.445400E-01 |
|
|
